Crispr Therapeutics shares owned by China Universal Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by China Universal Asset Management
from 13F filings
Historical chart of China Universal Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by China Universal Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $1.1M | 15k | 68.14 |
2023-12-31 | $575k | 9.2k | 62.55 |
2023-09-30 | $93k | 2.0k | 45.57 |
2023-06-30 | $58k | 1.0k | 56.09 |
2023-03-31 | $48k | 1.1k | 45.07 |
2022-12-31 | $146k | 3.6k | 40.58 |
2022-09-30 | $1.6M | 25k | 65.33 |
2022-06-30 | $81k | 1.3k | 60.77 |
2022-03-31 | $84k | 1.3k | 63.02 |
More positions owned by China Universal Asset Management
View all positions for China Universal Asset Management